$BICX Income Statement | Understand Stock

$BICX

$0.21 +$0.01 (4.48%) Close

Financial Statements

In USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues, net
Operating expenses:
Cost of implants and other costs
Research and development
Selling, general and administrative
Impairment of intellectual property
Depreciation and amortization
Total operating expenses
Loss from operations
Interest expense, net
Interest expense - related parties
Other income (expenses):
Interest expense - related parties
Interest expense, net
Loss on settlement of debt
Loss on contingency
Grant income
Change in fair value of upfront purchase price liability
Change in fair value of royalty liability
Other miscellaneous income
Total other (expenses) income, net
Net loss before provision for income taxes
Loss before provision for income taxes
Income taxes
Net loss
Non-controlling interest
Net loss per common share, basic and diluted
Weighted average number of common shares outstanding, basic and diluted

Net loss attributable to BioCorRx Inc.
Non-controlling interest
Dividend attributable to down round feature of warrants
Net loss per common share, basic and diluted
Weighted average number of common shares outstanding, basic and diluted

Comments